<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Dupont E I Nemours &amp; Company (Industry News &amp; Blogs)</title><link>http://www.zibb.com/healthcare/theme/cq/Dupont+E+I+Nemours+&amp;+Company</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/healthcare/theme/cq/Dupont+E+I+Nemours+&amp;+Company" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Mon, 23 Mar 2009 15:12:00 GMT</pubDate><lastBuildDate>Mon, 23 Mar 2009 15:12:00 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Dupont E I Nemours &amp; Company (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/healthcare/theme/cq/Dupont+E+I+Nemours+&amp;+Company</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Solutions to Prevent Contamination - a new information providing ...
      </title><link>http://www.realwire.com/release_detail.asp?ReleaseID=11718</link><description>DuPont Personal Protection has launched a brand new website dedicated to providing advice and information to assist customers’ in the correct selection of garments and wipes to ensure effective contamination control for every working environment. Whether in pharmaceuticals, agri-food, the</description><guid>http://www.realwire.com/release_detail.asp?ReleaseID=11718</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Mon, 23 Mar 2009 15:12:00 GMT</pubDate><source url="http://www.realwire.com" /></item><item><title>Pfizer's Statin Study: What An Email Response! (at CNBC)</title><link>http://www.cnbc.com/id/28069159/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</link><description>When I blogged earlier this week about two different studies about brand-name cardiovascular drugs, including statins, versus generic ones, I was simply trying to call attention to the timing between the two. (UPDATED: Pfizer responds. See Below.)</description><guid>http://www.cnbc.com/id/28069159/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Fri, 05 Dec 2008 14:44:36 GMT</pubDate><source url="http://www.cnbc.com" /></item><item><title>Aceto Corporation F1Q09 (Qtr End 09/30/08) Earnings Call Transcri...
      </title><link>http://seekingalpha.com/article/104809-aceto-corporation-f1q09-qtr-end-09-30-08-earnings-call-transcript?source=yahoo</link><description>Good morning, ladies and gentlemen, and welcome to the Aceto Corporation fiscal 2009 first quarter results conference call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. Please note that this conference is being recorded.</description><guid>http://seekingalpha.com/article/104809-aceto-corporation-f1q09-qtr-end-09-30-08-earnings-call-transcript?source=yahoo</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Fri, 07 Nov 2008 21:23:13 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Neogen: Safety first (SmallCapInvestor.com)</title><link>http://finance.yahoo.com/news/Neogen-Safety-smallcapinvestor-13413948.html</link><description>Most U.S. companies are gazing into cloudy crystal balls, trying to figure out what 2009 holds for them. At Neogen (NasdaqGS:NEOG - News), the first</description><guid>http://finance.yahoo.com/news/Neogen-Safety-smallcapinvestor-13413948.html</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Thu, 30 Oct 2008 10:20:01 GMT</pubDate><source url="http://finance.yahoo.com" /></item><item><title>Neogen: Safety first (SmallCapInvestor.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/smallcapinvestor/081030/12402.html?.v=2</link><description>Neogen: Safety first. - Most U.S. companies are gazing into cloudy crystal balls, trying to figure out what 2009 holds for them.</description><guid>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/smallcapinvestor/081030/12402.html?.v=2</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Thu, 30 Oct 2008 10:20:01 GMT</pubDate><source url="http://us.rd.yahoo.com" /></item><item><title>DuPont India Moves into Photovoltaic Market and Targets Revenue o...
      </title><link>http://www.industrialinfo.com/showAbstract.jsp?newsitemID=137798</link><description>BANGALORE, INDIA--August 29, 2008--Researched by Industrial Info Resources (Sugar Land, Texas)--As part of expansion initiatives aimed at achieving revenue of $1 billion by 2012, DuPont India (Hyderabad, Andhra Pradesh), a subsidiary of E.I. DuPont de Nemours &amp; Company (NYSE:DD) (Wilmington,</description><guid>http://www.industrialinfo.com/showAbstract.jsp?newsitemID=137798</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Fri, 29 Aug 2008 05:00:00 GMT</pubDate><source url="http://www.industrialinfo.com" /></item><item><title>Companies Report Success in Driving Safety Culture at Workplaces</title><link>http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&amp;STORY=/www/story/06-30-2008/0004841082&amp;EDATE=</link><description>"We are very pleased with the 2008 report and the survey results, in particular, because they reinforce the growing focus of safety as a cultural practice in companies around the world," said Mark P.</description><guid>http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&amp;STORY=/www/story/06-30-2008/0004841082&amp;EDATE=</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Mon, 30 Jun 2008 13:00:00 GMT</pubDate><source url="http://www.prnewswire.com" /></item><item><title>DuPont and Genencor International, Inc. Create World-Leading Cell...
      </title><link>http://www.biospace.com/news_story.aspx?StoryID=96328&amp;full=1</link><description> WILMINGTON, Del., and COPENHAGEN, Denmark, May 14 /PRNewswire- FirstCall/ -- DuPont and Genencor, a division of Danisco A/S, today announced an agreement to form DuPont Danisco Cellulosic Ethanol LLC, a 50/50 global joint venture to develop and commercialize the leading, low- cost technology</description><guid>http://www.biospace.com/news_story.aspx?StoryID=96328&amp;full=1</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Wed, 14 May 2008 12:00:00 GMT</pubDate><source url="http://www.biospace.com" /></item><item><title>Executive Moves: Icagen</title><link>http://www.contractpharma.com/news/2008/03/20/executive_moves%3a_icagen</link><description>Mark Suto, Ph.D. has been promoted to vice president of chemical and pharmaceutical sciences. Dr. Katz has held the position of senior vice president, finance and corporate development, and chief financial officer since 2001.</description><guid>http://www.contractpharma.com/news/2008/03/20/executive_moves%3a_icagen</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Thu, 20 Mar 2008 14:24:00 GMT</pubDate><source url="http://www.contractpharma.com" /></item><item><title>DuPont no. 1 innovator in chemical and biotech patents</title><link>http://www.news-medical.net/?id=36243</link><description>DuPont has achieved top rankings in science and patent strength according to several leading indicators published by The Patent Board and Nature Biotechnology. DuPont has achieved top rankings in science and patent strength according to several leading indicators published by The Patent Board and</description><guid>http://www.news-medical.net/?id=36243</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Thu, 13 Mar 2008 09:00:00 GMT</pubDate><source url="http://www.news-medical.net" /></item><item><title>ISA | DuPont, BP team on biofuel</title><link>http://www.isa.org/InTechTemplate.cfm?Section=Industry_News&amp;template=/ContentManagement/ContentDisplay.cfm&amp;ContentID=55078</link><description>The relationship between the two companies is not new. They have worked together since 2003 to develop advanced biofuels with properties that can help overcome the limitations of existing biofuels. The results of that work are now coming to market.</description><guid>http://www.isa.org/InTechTemplate.cfm?Section=Industry_News&amp;template=/ContentManagement/ContentDisplay.cfm&amp;ContentID=55078</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate /><source url="http://www.isa.org" /></item><item><title>Maxygen | News |</title><link>http://www.maxygen.com/newsview.php?listid=113</link><description>Redwood City, Calif., September 13, 2000 - Maxygen (Nasdaq: MAXY) today announced the issuance of U.S. Patent No. 6,117,679 expanding its patent position with respect to its proprietary MolecularBreeding directed molecular evolution technologies.</description><guid>http://www.maxygen.com/newsview.php?listid=113</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate /><source url="http://www.maxygen.com" /></item><item><title>News</title><link>http://www.huntsman.com/eng/News/News/Huntsman_Acquires_Global_Fluorochemical_Product_Line_for_Nonwovens_from_DuPont/index.cfm?PageID=7379&amp;News_ID=4715&amp;style=328</link><description>BASEL, Switzerland, July 25, 2007 - Huntsman Corporation today announced that its Textiles Effects business has signed an agreement to acquire DuPont's global fluorochemical business for the nonwovens industry.</description><guid>http://www.huntsman.com/eng/News/News/Huntsman_Acquires_Global_Fluorochemical_Product_Line_for_Nonwovens_from_DuPont/index.cfm?PageID=7379&amp;News_ID=4715&amp;style=328</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate /><source url="http://www.huntsman.com" /></item><item><title>AGFA.com - Press releases</title><link>http://www.impaxtech.com/en/co/news_events/index.jsp?pager=46</link><description>Agfa Graphics will be demonstrating its newest inkjet engines and solutions at the International Sign Association's (ISA) 60th Annual Sign Expo, being held in Orlando, FL (USA), next month.</description><guid>http://www.impaxtech.com/en/co/news_events/index.jsp?pager=46</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate /><source url="http://www.impaxtech.com" /></item><item><title>Senomyx: News: August 09, 2007</title><link>http://www.senomyx.com/news/2007Archives/news_080907.html</link><description>SAN DIEGO, CA - August 9, 2007 - Senomyx, Inc. (NASDAQ: SNMX), a company focused on using proprietary taste receptor technologies to discover novel flavor ingredients for the packaged food and beverage industry, today reported financial results for the second quarter ended June 30, 2007.</description><guid>http://www.senomyx.com/news/2007Archives/news_080907.html</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate /><source url="http://www.senomyx.com" /></item><item><title>Locus Pharmaceuticals - News - 2003 Press Releases - Locus Pharma...
      </title><link>http://www.locusdiscovery.com/news/2003/2003-01-21.php</link><description>Under the agreement, Locus will apply its proprietary computational technology to discover and develop novel small molecule compounds that have activity against key protein targets identified by DuPont Crop Protection.</description><guid>http://www.locusdiscovery.com/news/2003/2003-01-21.php</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate /><source url="http://www.locusdiscovery.com" /></item><item><title>Battle Lines: Natural Or Synthetic</title><link>http://www.hempworld.com/Hemp-CyberFarm_com/htms/articles/corpoworld1.html</link><description>USA -- Hemp is about life, renewal and future, power to The People...most everything America’s embedded fascist regime is not about. Government of, by and for corporations (CorpoGov) has us hogtied.</description><guid>http://www.hempworld.com/Hemp-CyberFarm_com/htms/articles/corpoworld1.html</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate /><source url="http://www.hempworld.com" /></item><item><title>Tyvek® Classic: protecting users from dust and dirt in cement pro...
      </title><link>http://www.realwire.com/release_detail.asp?ReleaseID=10863</link><description>Holcim Ltd is one of the world's leading producers of cement and aggregates. (1) At the Holcim (Deutschland) AG Lägerdorf  site in Northern Germany, employees working in cement production have switched from wearing disposable garments made of SMS material to wearing limited use type 5/6 chemical</description><guid>http://www.realwire.com/release_detail.asp?ReleaseID=10863</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Wed, 17 Dec 2008 14:46:00 GMT</pubDate><source url="http://www.realwire.com" /></item><item><title>Neogen Corporation F1Q09 (Qtr End 08/31/08) Earnings Call Transcr...
      </title><link>http://seekingalpha.com/article/99735-neogen-corporation-f1q09-qtr-end-08-31-08-earnings-call-transcript?source=yahoo</link><description>Welcome to the Neogen Corporation first quarter fiscal year 2009 earnings results conference call. (Operator Instructions) At this time for opening remarks and introductions, I would like to turn the conference over to Jim Herbert. Jim Herbert</description><guid>http://seekingalpha.com/article/99735-neogen-corporation-f1q09-qtr-end-08-31-08-earnings-call-transcript?source=yahoo</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Tue, 14 Oct 2008 01:05:21 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Aceto Corporation F4Q08 (Qtr End 06/30/08) Earnings Call Transcri...
      </title><link>http://seekingalpha.com/article/94163-aceto-corporation-f4q08-qtr-end-06-30-08-earnings-call-transcript?source=yahoo</link><description>This conference call contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended.</description><guid>http://seekingalpha.com/article/94163-aceto-corporation-f4q08-qtr-end-06-30-08-earnings-call-transcript?source=yahoo</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Fri, 05 Sep 2008 21:18:15 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Mystery Question-er On Merck &amp; Schering-Plough's Vytorin (at CNBC...
      </title><link>http://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11f67mrhq/*http://www.cnbc.com/id/25797882/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</link><description>Yesterday while covering the press conference about the new study on Merck and Schering-Plough's Vytorin I quoted the lead researcher, Dr. Terje Pedersen of Ulleval University Hospital in Oslo, Norway, who said--and this is a direct quote: "However, we had a disturbing finding when we looked at</description><guid>http://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11f67mrhq/*http://www.cnbc.com/id/25797882/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Tue, 22 Jul 2008 13:41:42 GMT</pubDate><source url="http://us.rd.yahoo.com" /></item><item><title>What's Ailing the Pharmaceutical Sector?</title><link>http://seekingalpha.com/article/81093-what-s-ailing-the-pharmaceutical-sector?source=feed</link><description>Marc Courtenay submits:Lou Basenese, The Associate Editor of the Oxford Club is a respected friend and colleague. With his permission, I want to share what he recently wrote on the pharmaceuticals (drug companies). He has</description><guid>http://seekingalpha.com/article/81093-what-s-ailing-the-pharmaceutical-sector?source=feed</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Thu, 12 Jun 2008 13:44:46 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>DuPont Finalizing Installation of Purification Unit at Tennessee ...
      </title><link>http://www.industrialinfo.com/showAbstract.jsp?newsitemID=132744</link><description>.I. DuPont de Nemours &amp; Company (NYSE:DD) (DuPont) (Wilmington, Delaware) is finalizing the installation of a new $30 million purification unit</description><guid>http://www.industrialinfo.com/showAbstract.jsp?newsitemID=132744</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Wed, 14 May 2008 13:29:20 GMT</pubDate><source url="http://www.industrialinfo.com" /></item><item><title>Neogen Corporation F1Q09 (Qtr End 08/31/08) Earnings Call Transcr...
      </title><link>http://seekingalpha.com/article/99735-neogen-corporation-f1q09-qtr-end-08-31-08-earnings-call-transcript?source=feed</link><description>Neogen Corporation (NEOG)F1Q09 Earnings CallComplete Story &lt;img</description><guid>http://seekingalpha.com/article/99735-neogen-corporation-f1q09-qtr-end-08-31-08-earnings-call-transcript?source=feed</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Tue, 14 Oct 2008 01:05:21 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Neogen Reports 26% Increase in Revenues (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080924/clw039.html?.v=101</link><description>Neogen Reports 26% Increase in Revenues. - LANSING, Mich., Sept. 24 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG - News) announced today that its revenues for the first quarter of FY 2009, which ended Aug. 31, increased 26% from the previous year's first quarter to $28,805,000.</description><guid>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080924/clw039.html?.v=101</guid><category domain="http://www.zibb.com">Dupont E I Nemours &amp; Company</category><pubDate>Wed, 24 Sep 2008 12:45:00 GMT</pubDate><source url="http://us.rd.yahoo.com" /></item></channel></rss>